tiprankstipranks
BioNexus Gene Lab’s Strategic Investment in AI Healthcare
Company Announcements

BioNexus Gene Lab’s Strategic Investment in AI Healthcare

Don't Miss Our Christmas Offers:

An announcement from BioNexus Gene Lab Corp (BGLC) is now available.

BioNexus Gene Lab Corp. has strategically invested RM 1 million to acquire a significant stake in Ascension Innovation Sdn Bhd, a Malaysian company specializing in AI healthcare solutions. This move is set to boost BioNexus’s market reach in genomic screening by leveraging Ascension’s digital health platforms, creating synergies that promise to enhance patient care and aid healthcare providers. The collaboration underscores BioNexus’s commitment to advancing in the digital health sector.

Find detailed analytics on BGLC stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBioNexus Gene Lab Faces Delisting and Leadership Changes
TheFlyBionexus unit, Protech Builders sign strategic teaming agreement
TheFlyBionexus Gene Lab in MOU with Shenzhen Rongguang Group for cancer screening
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App